Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
US5322847A · kind A · utility
55Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 1992 |
| Grant date | Jun 21, 1994 |
| Priority date | — |
| Expiry date | Nov 5, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A series of imidazo[4,5-c]pyridines which inhibit platelet activating factor (PAF) and also block leukotriene D4 receptors are useful in treating asthma, arthritis, psoriasis, gastrointestinal distress, myocardial infarction, stroke and shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.